scholarly journals Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans: associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency

2000 ◽  
Vol 41 (8) ◽  
pp. 1317-1327
Author(s):  
M.N. Nanjee ◽  
C.J. Cooke ◽  
W.L. Olszewski ◽  
N.E. Miller
1999 ◽  
Vol 82 (11) ◽  
pp. 1428-1432 ◽  
Author(s):  
Cheryl Scott ◽  
Francesco Salerno ◽  
Elettra Lorenzano ◽  
Werner Müller-Esterl ◽  
Angelo Agostoni ◽  
...  

SummaryLittle is known about the regulation of high-molecular-weight-kininogen (HK) and low-molecular-weight-kininogen (LK) or the relationship of each to the degree of liver function impairment in patients with cirrhosis. In this study, we evaluated HK and LK quantitatively by a recently described particle concentration fluorescence immunoassay (PCFIA) and qualitatively by SDS PAGE and immunoblotting analyses in plasma from 33 patients with cirrhosis presenting various degrees of impairment of liver function. Thirty-three healthy subjects served as normal controls. Patients with cirrhosis had significantly lower plasma levels of HK (median 49 μg/ml [range 22-99 μg/ml]) and LK (58 μg/ml [15-100 μg/ml]) than normal subjects (HK 83 μg/ml [65-115 μg/ml]; LK 80 μg/ml [45-120 μg/ml]) (p < 0.0001). The plasma concentrations of HK and LK were directly related to plasma levels of cholinesterase (P < 0.0001) and albumin (P < 0.0001 and P < 0.001) and inversely to the Child-Pugh score (P < 0.0001) and to prothrombin time ratio (P < 0.0001) (reflecting the clinical and laboratory abnormalities in liver disease). Similar to normal individuals, in patients with cirrhosis, plasma HK and LK levels paralleled one another, suggesting that a coordinate regulation of those proteins persists in liver disease. SDS PAGE and immunoblotting analyses of kininogens in cirrhotic plasma showed a pattern similar to that observed in normal controls for LK (a single band at 66 kDa) with some lower molecular weight forms noted in cirrhotic plasma. A slight increase of cleavage of HK (a major band at 130 kDa and a faint but increased band at 107 kDa) was evident. The increased cleavage of HK was confirmed by the lower cleaved kininogen index (CKI), as compared to normal controls. These data suggest a defect in hepatic synthesis as well as increased destructive cleavage of both kininogens in plasma from patients with cirrhosis. The decrease of important regulatory proteins like kininogens may contribute to the imbalance in coagulation and fibrinolytic systems, which frequently occurs in cirrhotic patients.


1978 ◽  
Vol 40 (02) ◽  
pp. 397-406 ◽  
Author(s):  
Joyce Low ◽  
J C Biggs

SummaryComparative plasma heparin levels were measured in normal subjects injected subcutaneously with 5,000 units of the sodium and calcium salts of heparin. Plasma heparin levels were measured up to 7 hr post-injection by an anti-factor Xa assay (Denson and Bonnar 1973). Preliminary studies indicated that heparin levels were reproducible in subjects who received two injections of the same heparin. Peak plasma concentrations (Cmax) and the time at which peak concentration was reached (Tmax) varied greatly from subject to subject. In one group of subjects (15) two commonly used heparins, a sodium heparin (Evans) and a calcium heparin (Choay) were compared. Peak heparin concentrations were not significantly different. However the Tmax for the sodium heparin (1.5 hr) was significantly earlier than the Tmax for the calcium heparin (3 hr) and this was not due to a difference in the volume of the two heparin injections. No significant difference could be detected in the plasma clearance rate and the molecular weight distribution of the two heparins.In two other groups of subjects, sodium and calcium preparations from two manufacturers were compared. In general, the sodium salts gave rise to significantly higher plasma concentrations, which could be interpreted as a greater bioavailability of sodium salts. These results indicate that the salt of the heparin can influence the plasma concentration achieved after subcutaneous injection.


1992 ◽  
Vol 33 (5) ◽  
pp. 745-754
Author(s):  
K Ishimura-Oka ◽  
CF Semenkovich ◽  
F Faustinella ◽  
IJ Goldberg ◽  
N Shachter ◽  
...  

2021 ◽  
Vol 88 (2) ◽  
pp. 111-112
Author(s):  
Kshitija Patil ◽  
Neerja Gupta

1996 ◽  
Vol 37 (5) ◽  
pp. 972-984
Author(s):  
F M Steinberg ◽  
E C Tsai ◽  
J D Brunzell ◽  
A Chait

2000 ◽  
Vol 7 (1) ◽  
pp. 45-49 ◽  
Author(s):  
Tomohiko Yoshida ◽  
Takanari Gotoda ◽  
Minoru Okubo ◽  
Yoko Iizuka ◽  
Shun Ishibashi ◽  
...  

2015 ◽  
Vol 241 (1) ◽  
pp. e139 ◽  
Author(s):  
E. Steinhagen-Thiessen ◽  
E. Stroes ◽  
H. Soran ◽  
C. Johnson ◽  
G. Iotti ◽  
...  

1969 ◽  
Vol 131 (1) ◽  
pp. 183-185 ◽  
Author(s):  
D. Baum ◽  
A. I. Schweid ◽  
D. Porte ◽  
E. L. Bierman

Sign in / Sign up

Export Citation Format

Share Document